{"id":234558,"date":"2026-09-08T11:49:46","date_gmt":"2026-09-08T06:19:46","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=234558"},"modified":"2026-09-08T11:49:47","modified_gmt":"2026-09-08T06:19:47","slug":"is-aptech-a-good-buy-after-q1-fy27-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/is-aptech-a-good-buy-after-q1-fy27-results\/","title":{"rendered":"Is Aptech a Good Buy After Its Q1 FY27 Results?"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Aptech share price around Rs 90. 34.4% below 52-week high of Rs 137. Q1 FY27 revenue Rs 138 crore, up 9.8% YoY. PAT Rs 7.65 crore, up 13.7%. PE 21x.<\/em><\/p>\n<div style=\"background: #F0F9FF; border-left: 4px solid #2E7D32; border-radius: 6px; padding: 14px 18px; margin: 18px 0;\">\n<p style=\"margin: 0; color: #1f4e79; font-size: 14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin: 8px 0 0;\">Aptech&#8217;s Q1 FY27 results were broadly steady, with revenue at Rs 138 crore and PAT at Rs 7.65 crore. The Aptech share price near Rs 90 has not moved sharply on this print, and investors asking whether Aptech is a good buy should look at the underlying margin trend rather than the headline numbers alone.<\/p>\n<\/div>\n<p>The<a href=\"https:\/\/univest.in\/user\/stocks\/aptecht\/aptech-ltd-share-price-today\"> Aptech<\/a> share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Aptech is a vocational training company offering IT, animation and beauty &amp; wellness education, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.<\/p>\n<p>Revenue for the quarter came in at Rs 138 crore, up 9.8% year on year, while profit after tax came in at Rs 7.65 crore, up 13.7% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Aptech share price from here.<\/p>\n<p>This piece works through the quarter&#8217;s financial highlights, the business factors behind the numbers, where the Aptech share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=aptech_q1fy27\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/is-aptech-a-good-buy-after-q1-fy27-results\/#Aptech_Q1_FY27_Financial_Highlights\" title=\"Aptech Q1 FY27 Financial Highlights\">Aptech Q1 FY27 Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/is-aptech-a-good-buy-after-q1-fy27-results\/#Aptech_Q1_FY27_Performance_Analysis\" title=\"Aptech Q1 FY27 Performance Analysis\">Aptech Q1 FY27 Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/is-aptech-a-good-buy-after-q1-fy27-results\/#Key_Business_Factors_in_Q1_FY27\" title=\"Key Business Factors in Q1 FY27\">Key Business Factors in Q1 FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/is-aptech-a-good-buy-after-q1-fy27-results\/#Revenue_Trend\" title=\"Revenue Trend\">Revenue Trend<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/is-aptech-a-good-buy-after-q1-fy27-results\/#Margin_Movement\" title=\"Margin Movement\">Margin Movement<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/is-aptech-a-good-buy-after-q1-fy27-results\/#Balance_Sheet_Position\" title=\"Balance Sheet Position\">Balance Sheet Position<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/is-aptech-a-good-buy-after-q1-fy27-results\/#Valuation_Context\" title=\"Valuation Context\">Valuation Context<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/is-aptech-a-good-buy-after-q1-fy27-results\/#Dividend_Details\" title=\"Dividend Details\">Dividend Details<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/is-aptech-a-good-buy-after-q1-fy27-results\/#Aptech_Share_Price_Outlook_for_FY27\" title=\"Aptech Share Price Outlook for FY27\">Aptech Share Price Outlook for FY27<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/is-aptech-a-good-buy-after-q1-fy27-results\/#Aptech_Stock_Performance\" title=\"Aptech Stock Performance\">Aptech Stock Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/is-aptech-a-good-buy-after-q1-fy27-results\/#Key_Risks\" title=\"Key Risks\">Key Risks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/is-aptech-a-good-buy-after-q1-fy27-results\/#Valuation_Risk\" title=\"Valuation Risk\">Valuation Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/is-aptech-a-good-buy-after-q1-fy27-results\/#Sector_and_Demand_Risk\" title=\"Sector and Demand Risk\">Sector and Demand Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/is-aptech-a-good-buy-after-q1-fy27-results\/#Execution_Risk\" title=\"Execution Risk\">Execution Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/is-aptech-a-good-buy-after-q1-fy27-results\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/is-aptech-a-good-buy-after-q1-fy27-results\/#Frequently_Asked_Questions_on_Aptech_Q1_FY27_Results\" title=\"Frequently Asked Questions on Aptech Q1 FY27 Results\">Frequently Asked Questions on Aptech Q1 FY27 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/is-aptech-a-good-buy-after-q1-fy27-results\/#What_were_Aptechs_Q1_FY27_results\" title=\"What were Aptech&#8217;s Q1 FY27 results?\">What were Aptech&#8217;s Q1 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/is-aptech-a-good-buy-after-q1-fy27-results\/#Is_Aptech_a_good_buy_after_its_Q1_FY27_results\" title=\"Is Aptech a good buy after its Q1 FY27 results?\">Is Aptech a good buy after its Q1 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/is-aptech-a-good-buy-after-q1-fy27-results\/#What_is_the_Aptech_share_price_today\" title=\"What is the Aptech share price today?\">What is the Aptech share price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/is-aptech-a-good-buy-after-q1-fy27-results\/#What_is_Aptechs_revenue_and_profit_for_Q1_FY27\" title=\"What is Aptech&#8217;s revenue and profit for Q1 FY27?\">What is Aptech&#8217;s revenue and profit for Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/is-aptech-a-good-buy-after-q1-fy27-results\/#Did_Aptech_declare_a_dividend_with_its_Q1_FY27_results\" title=\"Did Aptech declare a dividend with its Q1 FY27 results?\">Did Aptech declare a dividend with its Q1 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/is-aptech-a-good-buy-after-q1-fy27-results\/#What_is_Aptechs_PE_ratio_and_is_it_expensive\" title=\"What is Aptech&#8217;s PE ratio and is it expensive?\">What is Aptech&#8217;s PE ratio and is it expensive?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/is-aptech-a-good-buy-after-q1-fy27-results\/#What_are_the_key_risks_for_Aptech_investors_right_now\" title=\"What are the key risks for Aptech investors right now?\">What are the key risks for Aptech investors right now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/is-aptech-a-good-buy-after-q1-fy27-results\/#What_is_Aptechs_promoter_shareholding\" title=\"What is Aptech&#8217;s promoter shareholding?\">What is Aptech&#8217;s promoter shareholding?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Aptech_Q1_FY27_Financial_Highlights\"><\/span><strong>Aptech Q1 FY27 Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width: 100%; border-collapse: collapse;\">\n<thead>\n<tr style=\"background: #F0F0F0;\">\n<th style=\"border: 1px solid #BBBBBB; padding: 8px;\">Metric<\/th>\n<th style=\"border: 1px solid #BBBBBB; padding: 8px;\">Q1 FY27<\/th>\n<th style=\"border: 1px solid #BBBBBB; padding: 8px;\">Q1 FY26<\/th>\n<th style=\"border: 1px solid #BBBBBB; padding: 8px;\">YoY Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Revenue<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 138 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 125 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">9.8%<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">EBITDA<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 13 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 12 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">6.2%<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Operating Margin<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">9.7%<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">9.9%<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">NA<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Profit Before Tax<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 10 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 9.52 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">8.3%<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Net Profit \/ (Loss)<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 7.65 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">Rs 6.73 crore<\/td>\n<td style=\"border: 1px solid #BBBBBB; padding: 8px;\">13.7%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Aptech_Q1_FY27_Performance_Analysis\"><\/span><strong>Aptech Q1 FY27 Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check Aptech Fundamentals on Univest Screener<\/strong><\/a><\/p>\n<p>Revenue growth of 9.8% for the quarter came from steady demand across the company&#8217;s core business, keeping the topline trend intact for the vocational education and training services sector.<\/p>\n<p>Profitability moved broadly in line with revenue this quarter, with PAT at Rs 7.65 crore against Rs 6.73 crore a year earlier. There is no major surprise in either direction, and the Aptech share price has traded accordingly, without a sharp re-rating either way.<\/p>\n<p>On a sequential basis, revenue moved up 19.7% sequentially from Rs 115 crore in the March 2026 quarter and net profit moved up 329.8% sequentially from Rs 1.78 crore in the prior quarter, giving a fuller picture of the trend behind the Aptech share price than the year on year comparison alone.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Business_Factors_in_Q1_FY27\"><\/span><strong>Key Business Factors in Q1 FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Revenue_Trend\"><\/span><strong>Revenue Trend<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Aptech&#8217;s revenue grew 9.8% year on year this quarter, taking the quarterly base to Rs 138 crore in a vocational education and training services business that remains sensitive to demand and pricing cycles that ultimately feed through to the Aptech share price.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Margin_Movement\"><\/span><strong>Margin Movement<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>EBITDA rose 6.2% to Rs 13 crore, and operating margin moved to 9.7% from 9.9% a year earlier, a sign that cost control or pricing held up during the quarter.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Balance_Sheet_Position\"><\/span><strong>Balance Sheet Position<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Aptech carries a low debt-to-equity ratio of 0.05, giving it a conservative balance sheet heading into the rest of FY27.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Valuation_Context\"><\/span><strong>Valuation Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The stock trades at a PE of 21.1x against an industry average of 17.9x, a premium that this quarter&#8217;s results will need to justify going forward.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dividend_Details\"><\/span><strong>Dividend Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>No interim dividend was declared alongside Aptech&#8217;s Q1 FY27 results. The stock has not paid a meaningful dividend in the trailing twelve months. Investors tracking the Aptech share price for income should watch the company&#8217;s announcements around its next annual results for any dividend decision.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Aptech_Share_Price_Outlook_for_FY27\"><\/span><strong>Aptech Share Price Outlook for FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Aptech&#8217;s FY27 outlook looks steady rather than dramatic based on this quarter&#8217;s numbers. Investors should watch for any change in margin trend or demand commentary from management in the next results for a clearer signal on where the Aptech share price heads from here.<\/p>\n<p>Without a major catalyst in either direction, the Aptech share price is likely to keep tracking the company&#8217;s quarterly execution more than any single headline number.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Aptech_Stock_Performance\"><\/span><strong>Aptech Stock Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Aptech&#8217;s live share price and get daily stock updates.<\/em><\/p>\n<p>The Aptech share price was trading around Rs 90 as results season played out in late August 2026, roughly 34.4% below its 52-week high of Rs 137 and well above its 52-week low of Rs 69. Promoter holding stood at 47.4% as of the June 2026 quarter.<\/p>\n<p>The Aptech share price has moved without much drama on this result, consistent with a quarter that did not materially change the investment case either way. On profitability ratios, the company reports a return on equity of 9.46% and a book value of around Rs 62 per share, both useful reference points when judging whether the current price is reasonable.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks\"><\/span><strong>Key Risks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Valuation_Risk\"><\/span><strong>Valuation Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>At 21.1x earnings against an industry average of 17.9x, the stock leaves little room for disappointment if growth slows.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Sector_and_Demand_Risk\"><\/span><strong>Sector and Demand Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>As a vocational education and training services business, Aptech&#8217;s results remain tied to sector-specific demand, pricing and regulatory cycles that can shift from quarter to quarter and move the Aptech share price well before the next result.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Execution_Risk\"><\/span><strong>Execution Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Sustaining this quarter&#8217;s trend into the rest of FY27 depends on management execution on costs, pricing and demand, none of which are guaranteed.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Aptech&#8217;s Q1 FY27 results were steady rather than exciting, with revenue at Rs 138 crore and PAT at Rs 7.65 crore. The Aptech share price does not present a strong case either to buy aggressively or to avoid the stock based on this quarter alone, and investors should track the next result for a clearer trend.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Aptech_Q1_FY27_Results\"><\/span><strong>Frequently Asked Questions on Aptech Q1 FY27 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_were_Aptechs_Q1_FY27_results\"><\/span><strong>What were Aptech&#8217;s Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Aptech reported Q1 FY27 revenue of Rs 138 crore, up 9.8% year on year, and PAT of Rs 7.65 crore, up 13.7% year on year.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Aptech_a_good_buy_after_its_Q1_FY27_results\"><\/span><strong>Is Aptech a good buy after its Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Aptech&#8217;s results were largely in line with expectations this quarter, so the case to buy or avoid rests more on the broader trend than on this single print. Investors should form their own view based on their own risk appetite and time horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Aptech_share_price_today\"><\/span><strong>What is the Aptech share price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Aptech share price was trading around Rs 90 in late August 2026, about 34.4% below its 52-week high of Rs 137 and well above its 52-week low of Rs 69.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Aptechs_revenue_and_profit_for_Q1_FY27\"><\/span><strong>What is Aptech&#8217;s revenue and profit for Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Aptech reported revenue of Rs 138 crore and a net profit of Rs 7.65 crore for the quarter ended June 30, 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_Aptech_declare_a_dividend_with_its_Q1_FY27_results\"><\/span><strong>Did Aptech declare a dividend with its Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No interim dividend was declared alongside Aptech&#8217;s Q1 FY27 results. Investors should track the company&#8217;s next annual results for any dividend announcement.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Aptechs_PE_ratio_and_is_it_expensive\"><\/span><strong>What is Aptech&#8217;s PE ratio and is it expensive?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Aptech share price trades at a trailing PE of 21.1x, against an industry average of 17.9x. Investors should compare this with the company&#8217;s growth rate before judging value.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_for_Aptech_investors_right_now\"><\/span><strong>What are the key risks for Aptech investors right now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> At 21.1x earnings against an industry average of 17.9x, the stock leaves little room for disappointment if growth slows. Sustaining this quarter&#8217;s trend into the rest of FY27 depends on management execution on costs, pricing and demand, none of which are guaranteed.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Aptechs_promoter_shareholding\"><\/span><strong>What is Aptech&#8217;s promoter shareholding?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Promoter holding in Aptech stood at 47.4% as of the June 2026 quarter.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aptech Q1 FY27: revenue Rs 138 crore, PAT Rs 7.65 crore. Full results breakdown and whether the stock is a buy at current levels.<\/p>\n","protected":false},"author":35,"featured_media":234557,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[3802],"class_list":["post-234558","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["234557"],"_edit_lock":["1788848391:29"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["24"],"rank_math_seo_score":["74"],"rank_math_title":["Aptech Share Price: Is It a Good Buy After Q1 FY27 Results?"],"rank_math_description":["Aptech share price in focus after Q1 FY27 results: PAT at Rs 7.65 crore, revenue at Rs 138 crore. Full results breakdown and valuation check inside. Read the full analysis."],"rank_math_focus_keyword":["Aptech share price"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_edit_last":["29"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["42123"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/is-aptech-a-good-buy-after-q1-fy27-results.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/234558","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=234558"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/234558\/revisions"}],"predecessor-version":[{"id":234699,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/234558\/revisions\/234699"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/234557"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=234558"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=234558"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=234558"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}